SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001126234-22-000111
Filing Date
2022-11-14
Accepted
2022-11-14 07:29:49
Documents
15
Period of Report
2022-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lumo-20221114.htm   iXBRL 8-K 33594
2 EX-99.1 lumo-2022930x8kxex991.htm EX-99.1 113454
7 lumosa.jpg GRAPHIC 2692
  Complete submission text file 0001126234-22-000111.txt   322373

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lumo-20221114.xsd EX-101.SCH 2250
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lumo-20221114_def.xml EX-101.DEF 13048
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lumo-20221114_lab.xml EX-101.LAB 26049
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lumo-20221114_pre.xml EX-101.PRE 13926
9 EXTRACTED XBRL INSTANCE DOCUMENT lumo-20221114_htm.xml XML 10544
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 512-215-2630
LUMOS PHARMA, INC. (Filer) CIK: 0001126234 (see all company filings)

IRS No.: 421491350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35342 | Film No.: 221380241
SIC: 2834 Pharmaceutical Preparations